Briacell Therapeutics Corp Stock Shares Outstanding
| BCTXW Stock | USD 0.43 0.08 22.86% |
BriaCell Therapeutics Corp fundamentals help investors to digest information that contributes to BriaCell Therapeutics' financial success or failures. It also enables traders to predict the movement of BriaCell Stock. The fundamental analysis module provides a way to measure BriaCell Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BriaCell Therapeutics stock.
Common Stock Shares Outstanding is likely to climb to about 17.3 M in 2024. BriaCell | Shares Outstanding |
BriaCell Therapeutics Corp Company Shares Outstanding Analysis
BriaCell Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
BriaCell Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for BriaCell Therapeutics is extremely important. It helps to project a fair market value of BriaCell Stock properly, considering its historical fundamentals such as Shares Outstanding. Since BriaCell Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BriaCell Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BriaCell Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
BriaCell Shares Outstanding Historical Pattern
Today, most investors in BriaCell Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BriaCell Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of BriaCell Therapeutics shares outstanding as a starting point in their analysis.
BriaCell Therapeutics Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
BriaCell Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, BriaCell Therapeutics Corp has 0.0 of shares currently outstending. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
BriaCell Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BriaCell Therapeutics' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BriaCell Therapeutics could also be used in its relative valuation, which is a method of valuing BriaCell Therapeutics by comparing valuation metrics of similar companies.BriaCell Therapeutics is currently under evaluation in shares outstanding category among its peers.
BriaCell Therapeutics Current Valuation Drivers
We derive many important indicators used in calculating different scores of BriaCell Therapeutics from analyzing BriaCell Therapeutics' financial statements. These drivers represent accounts that assess BriaCell Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BriaCell Therapeutics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 6.8M | 77.8M | 99.9M | 102.8M | 92.5M | 97.1M | |
| Enterprise Value | 7.0M | 20.6M | 58.8M | 81.5M | 73.4M | 77.0M |
BriaCell Fundamentals
| Return On Equity | -2.06 | ||||
| Return On Asset | -1.26 | ||||
| Number Of Shares Shorted | 2.94 K | ||||
| EBITDA | (4.79 M) | ||||
| Net Income | (4.93 M) | ||||
| Total Debt | 8.56 M | ||||
| Book Value Per Share | (0.13) X | ||||
| Cash Flow From Operations | (24.13 M) | ||||
| Beta | 1.82 | ||||
| Market Capitalization | 48.08 M | ||||
| Total Asset | 5.87 M | ||||
| Retained Earnings | (85.44 M) | ||||
| Working Capital | (3.81 M) | ||||
| Net Asset | 5.87 M |
About BriaCell Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BriaCell Therapeutics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BriaCell Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BriaCell Therapeutics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BriaCell Stock Analysis
When running BriaCell Therapeutics' price analysis, check to measure BriaCell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BriaCell Therapeutics is operating at the current time. Most of BriaCell Therapeutics' value examination focuses on studying past and present price action to predict the probability of BriaCell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BriaCell Therapeutics' price. Additionally, you may evaluate how the addition of BriaCell Therapeutics to your portfolios can decrease your overall portfolio volatility.